Skip to content

Medical emergency? What to do

Link between rheumatoid arthritis and cancer examined

3-RXPublished March 1, 20063 min read

Key points

  • Rheumatoid arthritis is an inflammatory disease of the immune system and is thought to be linked to an increased risk of cancers of the lymphatic system.
  • Although various studies have noted this link, none have been able to pinpoint the specific effects of the disease on lymphoma risk, let alone distinguish them from the effects of disease treatment.
  • Their findings appear to indicate there is a substantially increased risk of lymphoma among patients with severe RA, who have very high and prolonged inflammatory activity, and not by the treatment used.
  • Using statistical analysis, the relative risks or odds ratios for lymphoma were assessed for three different levels of overall disease activity - low, medium, or high - based on disease duration and swollen and tender joint counts.

Rheumatoid arthritis is an inflammatory disease of the immune system and is thought to be linked to an increased risk of cancers of the lymphatic system.

The lymphatic system plays an important part in the body's ability to fight infection.

Although various studies have noted this link, none have been able to pinpoint the specific effects of the disease on lymphoma risk, let alone distinguish them from the effects of disease treatment.

In the past it has been unclear whether certain RA patients were more vulnerable to developing lymphoma or whether certain RA therapies, ranging from standard NSAIDs (nonsteroidal anti-inflammatory drugs) and DMARDs (disease-modifying antirheumatic drugs), to the new immunosuppressive agents such as TNF (tumor necrosis factor) blockers,alleviate or aggravate the lymphoma risk.

Researchers in Sweden have conducted the largest investigation of this supposed link to date.

Their findings appear to indicate there is a substantially increased risk of lymphoma among patients with severe RA, who have very high and prolonged inflammatory activity, and not by the treatment used.

Using data from a national register of nearly 75,000 RA patients, the research team analyzed the medical records and case histories of 378 RA patients afflicted with malignant lymphoma between 1964 and 1995 and 378 individually matched, lymphoma-free controls.

Using statistical analysis, the relative risks or odds ratios for lymphoma were assessed for three different levels of overall disease activity - low, medium, or high - based on disease duration and swollen and tender joint counts.

Odds ratios for lymphoma were also compared to treatment in broad categories: any DMARD, any NSAID, aspirin, oral steroids, injected steroids, and cytotoxic drugs. No patient in the sample had received anti-TNF therapy. In addition, lymphoma specimens were reclassified and tested for Epstein-Barr virus (EBV).

Compared with low RA activity, medium RA activity was associated with an 8-fold increase in the risk for lymphoma. The odds ratio rose dramatically for high RA activity - to a 70-fold increase in lymphoma risk.

The researchers also observed increased risks of lymphoma associated with pronounced, irreversible joint damage in the hands, feet, and knees documented in the last year before lymphoma diagnosis.

Of all the medical treatments assessed, researchers observed increased lymphoma risk associated only with azathioprine (AZA), which is not regarded as a traditional DMARD for RA and rarely used in current treatment.

Lead author, Dr. Lars Klareskog of Karolinska University Hospital in Stockholm, says the study has substantial clinical implications given the many uncertainties surrounding the link between lymphoma and chronic inflammatory diseases.

Klareskog says since a lymphoma risk is strongly associated with exceptionally severe and longstanding RA activity, aggressive treatment may reduce the risk by reducing inflammation.

The study is published in the March 2006 issue of Arthritis & Rheumatism.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underArthritis

Keep reading

Arthritis

Higher U.S. arthritis due to obesity

The higher prevalence of arthritis in the United States may be a consequence of greater U.S. obesity and physical inactivity, Canadian researchers say. Researchers from the Toronto Western Research Institute noted a…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.